πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 16 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8734527

Encapsulated kidney tissue

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518390

Treatment of stroke and other acute neural degenerative disorders via intranasal administr

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8491883

Treatment of amyotrophic lateral sclerosis using umbilical derived cells

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435943

Protein stabilization formulations

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8361459

Treatment of stroke and other acute neural degenerative disorders using postpartum-derived

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318483

Postpartum cells derived from umbilical cord tissue, and methods of making and using the s

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8277796

Regeneration and repair of neural tissue using postpartum-derived cells

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8277831

Drug-enhanced adhesion prevention

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8197838

Sustained release systems of ascorbic acid phosphate

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076294

Collagen-related peptides and uses thereof

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071137

Method for treatment of cartilage disorders with centella extract

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058237

Stable composition of GDF-5 and method of storage

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8034363

Sustained release systems of ascorbic acid phosphate

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8034329

Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7964561

Protein formulations for use at elevated temperatures

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947649

Liquid buffered GDF-5 formulations

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted